What Researchers Did
Researchers reviewed the applicability of animal tumor data to human cancer therapy, focusing on tumor hypoxia, dose fractionation, and chemo-radiotherapy.
What They Found
The review highlighted that applying animal tumor data to human cancer therapy is complex, with many instances of premature application or inadequate consideration of animal observations in clinical study design. It explored how animal models have informed clinical trials in three key areas: tumor hypoxia, dose fractionation, and chemo-radiotherapy, emphasizing their utility beyond just screening new agents.
What This Means for Canadian Patients
This review suggests that carefully considering animal tumor data can lead to more effective and safer cancer treatments for patients by improving the design of clinical trials. By understanding the strengths and limitations of animal models, future therapies for conditions like tumor hypoxia and various radiation and chemotherapy regimens could be optimized for better patient outcomes.
Canadian Relevance
This study has no specific Canadian connection.
Study Limitations
As a review from 1988, this study's insights into the applicability of animal tumor data may not fully reflect current advancements in cancer research and clinical trial methodologies.